DeepHealth vs Hyperfine Swoop

Swoop is capital equipment. The FY2025 10-K describes ownership plus an annual software, service and support agreement after a one-year warranty, on 36- or 60-month terms, against about $1.2 million for a conventional MRI, and an older paper estimated $50,000 per system. No price is public. The system is a 0.064T portable brain MRI that needs no shielded room, with T1, T2, FLAIR and DWI sequences and Optive AI reconstruction carrying CE and UKCA marks since August 2025. Hyperfine has 17 openFDA records, the latest K262622 in August 2026. Image quality sits below 1.5T and 3T and there is no contrast-enhanced T1. An ICU that cannot move a patient to the scanner, or a hospital in a resource-limited setting, is the Swoop buyer. Hyperfine is Nasdaq-listed, and a Yahoo Finance summary puts its Q2 2026 net loss at $9.3 million. DeepHealth is software for reading mammography, prostate and lung images, owned by RadNet, so no buyer chooses between it and a magnet. An outpatient group reading screening mammograms and prostate MRs takes DeepHealth.